Results 161 to 170 of about 10,481 (199)
Exploratory Evaluation of Peptide-Based Immunization Targeting Fusion Glycoprotein-Derived Epitopes of Nipah Virus in Murine Model. [PDF]
Vaccines (Basel)Moon SY +9 more
europepmc +1 more source
Cell-cell fusion limits activation of the unfolded protein response induced by the Nipah virus glycoproteins. [PDF]
J VirolJordan P +5 more
europepmc +1 more source
Targeting Nipah virus replication: A fluorescence polarization assay for high-throughput modulators screening against the N<sub>TAIL</sub>-XD interaction. [PDF]
J Biol ChemBost H, Derviaux C, Longhi S.
europepmc +1 more source
The role of infection prevention and control in the mitigation of human-to-human transmission of Nipah virus: a systematic review. [PDF]
Antimicrob Resist Infect ControlPritchard S, Hornsey E.
europepmc +1 more source
International Research Journal of Modernization in Engineering Technology and Scienceopenaire +1 more source
Origin and evolution of Nipah virus
Journal of Medical Virology, 2015 Nipah virus, member of the Paramyxoviridae family, is classified as a Biosafety Level‐4 agent and category C priority pathogen. Nipah virus disease is endemic in south Asia and outbreaks have been reported in Malaysia, Singapore, India, and Bangladesh. Bats of the genus Pteropus appear to be the natural reservoir of this virus.
A. Lo Presti +6 more
openaire +4 more sources